These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2830406)

  • 1. Mopidamol in non-small cell lung cancer: anti-oncogene or accident?
    Livingston RB
    J Natl Cancer Inst; 1988 Mar; 80(2):77-8. PubMed ID: 2830406
    [No Abstract]   [Full Text] [Related]  

  • 2. Mopidamol.
    J Natl Cancer Inst; 1988 Jun; 80(7):532-4. PubMed ID: 2835491
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188.
    Zacharski LR; Moritz TE; Baczek LA; Rickles FR; Edwards RL; Forman WB; Forcier RJ; Cornell CJ; Haakenson CM; Ballard HS
    J Natl Cancer Inst; 1988 Mar; 80(2):90-7. PubMed ID: 2830407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adjuvant therapy of non-small cell bronchial cancer with mopidamol].
    Blaha H; Dierkesmann R; Feuerer W; Gatzemaier U; Geser C; Lemme J; Mall W; Ritscher R; Schneider B; Vallee D
    Pneumologie; 1989 Jun; 43(6):299-304. PubMed ID: 2547216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory action of flurbiprofen and mopidamole on tumor lung metastasis formation in mice.
    Mamytbeková A; Rezábek K; Grimová J; Svobodová J
    Cancer Treat Rep; 1987 Nov; 71(11):1089-90. PubMed ID: 3677114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.
    Mamytbeková A; Rezábek K; Kacerovská H; Grimová J; Svobodová J
    Neoplasma; 1986; 33(4):417-21. PubMed ID: 3762804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.
    Zacharski LR; Rickles FR; Henderson WG; Martin JF; Forman WB; Van Eeckhout JP; Cornell CJ; Forcier RJ
    Am J Clin Oncol; 1982 Dec; 5(6):593-609. PubMed ID: 6299092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular-targeted drug for non-small cell lung cancer].
    Okamoto I
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():438-42. PubMed ID: 23513880
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimetastatic and antitumor effect of platelet aggregation inhibitors.
    Ambrus JL; Ambrus CM; Gastpar H; Huberman E; Montagna R; Biddle W; Leong S; Horoszewicz J
    Prog Clin Biol Res; 1982; 89():97-111. PubMed ID: 7111312
    [No Abstract]   [Full Text] [Related]  

  • 10. Ceritinib (Zykadia) for non-small cell lung cancer.
    Med Lett Drugs Ther; 2014 Jul; 56(1447):62-3. PubMed ID: 25046419
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiplatelet pyrimido-pyrimidines and metastasis.
    Lichtner RB; Hutchinson G; Wedderburn N; Hellmann K
    Cancer Treat Rev; 1985 Dec; 12(4):221-34. PubMed ID: 3009013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer.
    Kris MG; Gralla RJ; Burke MT; Berkowitz LD; Marks LD; Kelsen DP; Heelan RT
    Cancer Treat Rep; 1987; 71(7-8):763-4. PubMed ID: 3038318
    [No Abstract]   [Full Text] [Related]  

  • 13. [Non-small cell lung cancer: Remarkable developments].
    Vignot S; Wislez M
    Bull Cancer; 2015 Dec; 102(12):962-3. PubMed ID: 26597477
    [No Abstract]   [Full Text] [Related]  

  • 14. Two drugs beat back lung tumors.
    Cancer Discov; 2015 Feb; 5(2):100. PubMed ID: 25656878
    [No Abstract]   [Full Text] [Related]  

  • 15. The new drugs and biologics as sensitizers in the treatment of non-small cell lung cancer.
    Turrisi AT
    Suppl Tumori; 2002; 1(4):S55-7. PubMed ID: 12415822
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrovascular blockade associated with thoracotomy and its prevention with a platelet inhibitor.
    Patterson RH
    Ann Thorac Surg; 1976 Jan; 21(1):38-42. PubMed ID: 1247322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceritinib versus chemotherapy in ALK-positive lung cancer.
    Marshall H
    Lancet Respir Med; 2016 Dec; 4(12):952-953. PubMed ID: 27838332
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib.
    Toyokawa G; Inamasu E; Shimamatsu S; Yoshida T; Nosaki K; Hirai F; Yamaguchi M; Seto T; Takenoyama M; Ichinose Y
    J Thorac Oncol; 2015 Jul; 10(7):e55-7. PubMed ID: 26134233
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of EML4-ALK fusion gene as a biomarker in non-small cell lung cancer].
    Wang L; Wang YH; Liu CY; Han M; Zhang SP; Lai RS
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):788-90. PubMed ID: 22336170
    [No Abstract]   [Full Text] [Related]  

  • 20. Brigatinib effective in ALK-positive non-small-cell lung cancer.
    Das M
    Lancet Oncol; 2017 Jun; 18(6):e310. PubMed ID: 28506557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.